The global market for conjugate vaccines will expand at a CAGR of 146% to reach a value of USD 10059 Bn by 2023 Increased adoption of therapeutic vaccines for cancer  improved patient compliance  a larger product pipeline  and efforts to promote adoption of screening methods are some of the factors that will lead to the growth of the market